A5012330770- Nutrition and Health in Aging
- COVID-19 Clinical Research Studies
- Hemophilia Treatment and Research
- MicroRNA in disease regulation
- Platelet Disorders and Treatments
- Frailty in Older Adults
- Colorectal and Anal Carcinomas
- Colorectal Cancer Screening and Detection
- Head and Neck Cancer Studies
- Gastric Cancer Management and Outcomes
- Public Health and Nutrition
- COVID-19 Impact on Reproduction
- Bladder and Urothelial Cancer Treatments
- FinTech, Crowdfunding, Digital Finance
- SARS-CoV-2 and COVID-19 Research
- Hemostasis and retained surgical items
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- COVID-19 diagnosis using AI
Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
2017-2024
University of Indonesia
2017-2024
Abstract Background Cellular immunity as reflected by total lymphocyte count (TLC) has been proven to be related overall survival rate cancer patients. Lymphocyte proliferation is regulated, some extent, nutritional factor. Branched chain amino acid (BCAA) documented one of numerous nutrients that play important role in through its effect on protein synthesis and DNA replication. Many studies describe the correlation between BCAA TLC hepatic This study emphasized observation links head neck...
Introduction: Indonesia, as a developing country, has limited data on the factors associated with 30-day mortality in COVID-19 patients Indonesia. As matter of fact, study analyzing infection Indonesia never been conducted. This aims to fill this gap literature by conducting large-scale analysis Method: employed single-center retrospective cohort observational design, and was conducted at Cipto Mangunkusumo National General Hospital between years 2022 2023. Sampling using consecutive...
<ns3:p>Background Understanding the demographics, tumor characteristics, genetic mutations, and immune scores in colorectal cancer (CRC) patients may aid tailoring treatment predicting survival. Methods This retrospective cohort study assessed clinical parameters, scores, their relationship with survival CRC. Results The included 74 patients, mean age 53.7 years, mostly male (53.3%) aged 41-70 (77.3%). Common comorbidities cardiovascular diseases (29.3%) hypertension (21.3%). Adenocarcinoma...
<b>Background</b>: In the era of coronavirus disease 2019 (COVID-19), it is mandatory to identify vulnerable people with cancers as they have impaired immune system that can lead high mortality. This study analyzes complete blood count (CBC) derived inflammatory biomarkers and level anti-SARS-CoV-2 neutralizing antibody (NAb) spike protein’s receptor-binding domain immunoglobulin G (S-RBD IgG) among cancer survivors.<br /> <b>Methods</b>: A cross-sectional was...
Pendahuluan. Salah satu fokus perawatan pasien hemofilia adalah meningkatkan kualitas hidup terkait kesehatan. Akibat keterbatasan biaya kesehatan, kebijakan pemberian faktor VIII di Indonesia saat ini masih dilakukan secara on demand. Hal akan komplikasi muskuloskeletal dan menurunkan dewasa. Penelitian bertujuan untuk menilai pada dewasa faktor-faktor yang mempengaruhinyaMetode. Studi merupakan studi potong lintang selama bulan Maret–Mei 2012. Subjek penelitian berusia 18 tahun atau lebih...
Introduction. Geriatric syndromes is associated with poor survival, quality of life and increased chemotoxicity risk in elderly receiving chemotherapy. currently not routinely evaluated pre-chemotherapy clinical setting. This study aimed to identify the prevalence some geriatric patients undergoing chemotherapy.Methods. part primary investigating cancer. A descriptive cross sectional during March 2020 – 2021 was conducted before chemotherapy administration Cipto Mangunkusumo Hospital, a...
Background: Bladder cancer is the most common type of in urinary system and eleventh world. The overall 5-year survival bladder metastatic stage very low. standard first-line chemotherapy for M-VAC (methotrexate, vinblastine, doxorubicin, cisplatin) GC (gemcitabine, while second-line vinflunine. Gemcitabine has shown a higher response rate than vinflunine as treatment. But, survival-rate gemcitabine still unknown. Objective: To determine whether monotherapy can increase carcinoma after prior...